← Leaderboards
Howard W Davidson
University Of Colorado Denver
$4,356,743
Attributed
$4,866,598
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $813.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,866,598 · 7
By mechanism
R01$3,392,410 · 2
R21$729,370 · 2
R56$592,563 · 2
R03$152,255 · 1
Top collaborators
- John C Hutton2 shared
- Holger A. Russ2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Jill M Norris$16,405,166
- Maki Nakayama$6,654,561
- George S Eisenbarth$13,354,570
- Marian J. Rewers$53,889,410
- John C Hutton$5,451,482
Research focus
Insulin-Dependent Diabetes MellitusInsulinDiabetes MellitusBaseAutoantibodiesClinical TrialsBeta CellAutoimmune DiseasesMemberMediatingCellsChronic DiseaseIn VitroEpitopesAutoantigensChildInsightBiological MarkersAutoreactive T CellDiabeticElderlyImmune SystemAntigensHigh Risk
Grant awards (16)
Multimodal analysis of the "honeymoon period" in autoimmune diabetes$526,043
R01 · FY2025 · DK · contact PI
Multimodal analysis of the "honeymoon period" in autoimmune diabetes$495,495
R01 · FY2024 · DK · contact PI
Multimodal analysis of the "honeymoon period" in autoimmune diabetes$516,140
R01 · FY2023 · DK · contact PI
Multimodal analysis of the "honeymoon period" in autoimmune diabetes$516,140
R01 · FY2022 · DK · contact PI
Stress induced changes to the human beta cell proteome$194,375
R21 · FY2020 · AI · contact PI
Stress induced changes to the human beta cell proteome$233,250
R21 · FY2019 · AI · contact PI
Cloning of molecular targets of Cell Mediated Autoimmunity in Type 1 Diabetes$327,011
R01 · FY2014 · DK · contact PI
Cloning of molecular targets of Cell Mediated Autoimmunity in Type 1 Diabetes$315,566
R01 · FY2013 · DK · contact PI
Cloning of molecular targets of Cell Mediated Autoimmunity in Type 1 Diabetes$327,242
R01 · FY2012 · DK · contact PI
Analysis of diabetogenic human T cell receptors$369,250
R56 · FY2011 · AI · contact PI
Cloning of molecular targets of Cell Mediated Autoimmunity in Type 1 Diabetes$368,773
R01 · FY2011 · DK
Development of novel diabetes autoantibody assays based on luciferase reporters$75,735
R03 · FY2011 · AI · contact PI
Cloning of molecular targets of CMI in type 1 diabetes$223,313
R56 · FY2010 · DK
Development of novel diabetes autoantibody assays based on luciferase reporters$76,520
R03 · FY2010 · AI · contact PI
Active tolerosomes, a novel therapy for type 1 diabetes$147,745
R21 · FY2006 · DK · contact PI
Active tolerosomes, a novel therapy for type 1 diabetes$154,000
R21 · FY2005 · DK